CANBERRA, Australia, April 23, 2025 /PRNewswire/ — Liquid Instruments, a leader in reconfigurable test and measurement technology, today announced the appointment of two new board members, Nobel Prize-winning physicist Professor Brian Schmidt and Liquid Instruments’ co-founder, Danielle Wuchenich.

Schmidt, an active scientist at the Australian National University’s Research School of Astronomy and Astrophysics, brings decades of expertise in precision measurement techniques to Liquid Instruments. His Nobel Prize-winning research into the accelerating expansion of the universe exemplifies his ability to push scientific boundaries.

“Brian’s exceptional background in physics, combined with his proven leadership in academia and advocacy for science education, makes him an ideal addition to our board,” said Daniel Shaddock, co-founder and CEO of Liquid Instruments. “His insights will help guide the company as it continues to innovate at the intersection of advanced instrumentation and artificial intelligence, while expanding product manufacturing in Australia.”

Wuchenich also joined the Board of Directors. As co-founder of Liquid Instruments, Wuchenich has been instrumental in building the company’s commercial operations, including sales and marketing, and driving growth since its inception. She holds a Ph.D. in physics from the Australian National University.

Liquid Instruments has expanded rapidly in Australia over the past year, fueled by a $12 million investment in June 2024 led by Breakthrough Victoria. The company recently established a new office in Melbourne to enhance research and development. It has also transitioned its product manufacturing operations to Australia, reinforcing domestic supply chains and creating new high-skilled jobs in engineering, software development, and machine learning — with dozens more roles to be filled.

These moves align with national initiatives to strengthen Australia’s technology sector, positioning Liquid Instruments as a key player in the country’s manufacturing ecosystem. The company’s goal to develop local talent, combined with its investment in cutting-edge AI capabilities, reinforces its dedication to building Australia’s future technology workforce.

“Liquid Instruments is redefining what’s possible in test and measurement,” Schmidt said. “I’m thrilled to join a company that champions innovation in science and engineering and supports science education around the world.”

To learn more, visit https://liquidinstruments.com.

About Liquid Instruments     

Developing complex technologies requires increasingly sophisticated test systems, but the uniqueness of most applications demands adaptable, customized configurations. Traditional multi-instrument setups add significant cost and time, both upfront and throughout the test cycle. Liquid Instruments’ reconfigurable Moku is the only integrated test solution engineered for seamless customization — whether for simple tests or intricate multi-instrument environments. Used in hundreds of labs worldwide, Moku accelerates the journey from idea to implementation by an order of magnitude, cutting the time and cost of advanced research and development. Designed by researchers for researchers, Moku delivers unparalleled efficiency in today’s most complex test scenarios while adapting to your evolving needs in the future. Experience Moku cost-free by requesting a demo today at https://liquidinstruments.com.

Liquid Instruments Media Contact
ICR for Liquid Instruments
liquidinstruments@icrinc.com

Logo – https://laotiantimes.com/wp-content/uploads/2025/04/liquid_instruments_logo.jpg

NEW YORK, April 23, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

Kristen Scholer delivers the pre-market update on April 23rd

• Stocks are rallying early Wednesday after President Trump softened his stance on Fed Chair Powell and the U.S. toned down tariff talk on China.
• The S&P 500 traded up 2.5% pre-market on Wednesday, after a 2.5% gain on Tuesday.
• Elon Musk announced Tuesday that he will significantly scale back his time spent running DOGE after Tesla earnings and sales missed estimates last quarter.

Opening Bell
Elm Wealth celebrates the Elm Market Navigator ETF (NYSE Arca: ELM)

Closing Bell
Rockefeller Asset Management celebrates the recent listing of the Rockefeller Opportunistic Municipal Bond ETF, The Rockefeller US Small-Mid Cap ETF, and the Rockefeller Global Equity ETF (NYSE ARCA: RMOP, RSMC, RGEF)

Watch NYSE TV Live every weekday 9:00-10:00am ET

Video – https://mma.prnasia.com/media2/2671253/NYSE_Market_Update_April_23_2025.mp4

Eight presentations, including late-breaking science, live cases, and a landmark symposium

CARDIFF-BY-THE-SEA, Calif., April 23, 2025 /PRNewswire/ — Field Medical Inc., a leader in cardiac pulsed field ablation (PFA) technology, announced today its FieldForce™ Ablation System will be featured in eight scientific presentations at the 46^th annual Heart Rhythm Society (HRS) meeting, April 24–27, in San Diego, Calif.

HRS 2025, the premier global meeting for heart rhythm science, is expected to draw more than 9,000 attendees and 2,000 expert faculty. Field Medical joins this record-breaking lineup with eight presentations spanning live case demonstrations, poster sessions, and a flagship satellite symposium—culminating in the late-breaking VCAS trial on Sunday, April 27, where acute results from the first-in-human evaluation of focal PFA for scar-related ventricular tachycardia (VT) will be unveiled. This novel approach targets scar VT, a notoriously difficult arrhythmia marked by dense fibrotic substrates and high recurrence rates.

Field Medical’s proprietary FieldForce Ablation System, a high-voltage, focal PFA catheter, will be featured across live cases, poster sessions and a flagship satellite symposium – spotlighting its potential to expand next-generation PFA access for complex cardiac ablation.

“For decades, VT has challenged even the most skilled electrophysiologists due to the complexity of the scar substrate,” said Steven Mickelsen, MD, CEO and Founder of Field Medical. “With FieldForce we’re not just iterating—we’re redefining what’s possible. This new focal PFA system has the potential to bring PFA to the areas of greatest unmet need in electrophysiology, and the momentum we’re seeing at Heart Rhythm 2025 reflects that.”

As part of Heart Rhythm 2025, Field Medical’s participation underscores its commitment to advancing science, improving outcomes, and shaping the next chapter in VT and PFA innovation.

Field Medical scientific presentations and events at Heart Rhythm 2025

Innovation Spotlight | Stanford Biodesign
New Arrhythmia Technologies Retreat – April 23 – Dr. Steven Mickelsen

Late-Breaking Clinical Trial | Room 6DE
VCAS: First-in-Human Focal PFA for Scar VT – April 27, 11:15–11:25 a.m. – Dr. Vivek Reddy

Live Case Demonstrations | PFA Live Case Summit | Room 20A
VT with Focal Force-Sensing PFA – April 24, 11:20 a.m.–12:50 p.m. – Drs. Vivek Reddy and Petr Neužil
PVI with FieldForce™ (Focal PFA) – April 24, 3:20–4:50 p.m. – Drs. Vivek Reddy and Petr Neužil

Poster Presentations | Abstract Pavilion, Exhibit Hall
Treatment of Refractory VT with Investigational PFA System – April 25, 10:30 a.m.–12:30 p.m. – Dr. Cory Tschabrunn
Transmural Lesions with Focal PFA – April 26, 9:30–11:30 a.m. – Dr. Vivek Reddy
Scar Modulation via MRI Post-PFA – April 26, 12:00–2:00 p.m. – Dr. Colin Blumenthal

Satellite Symposium | San Diego Wine & Culinary Center
PFA in the Ventricle: The Future of Ablation – April 25, 6:00 p.m. (includes dinner)
Presenting faculty: Drs. Pierre Jais, Jacob Koruth, Damijan Miklavčič, Steven Mickelsen, Kars Neven, Andrea Natale, Vivek Reddy, and Roderick Tung

About Field Medical^® Inc.
Founded in 2022, Field Medical is advancing next-generation pulsed field ablation (PFA) technologies to address the complex needs of modern cardiac ablation. The company is led by Dr. Steven Mickelsen, a pioneer in pulsed electric field technology and a leading innovator in the field. His foundational work in PFA established the basis for modern advancements in the technology, which Field Medical continues to refine with its groundbreaking solutions. In 2024, Field Medical’s technology was recognized by the FDA with Breakthrough Device Designation and inclusion in the TAP Pilot Program. 

For more information, visit www.fieldmedicalinc.com and follow us on LinkedIn and X.

The FieldForce™ Ablation System is an investigational device and is limited by federal (or United States) law to investigational use.

Media Contact
Holly Windler
619.929.1275
Holly.windler@gmail.com

Field Medical: Engineered to reach the epicardium from the endocardium, the FieldForce™ Ablation System catheter is designed to enable focal pulsed field ablation for full-thickness, transmural lesions.

SHANGHAI, April 23, 2025 /PRNewswire/ — On April 23, the 21st Auto Shanghai officially kicked off.

At this year’s auto show, GAC, with safety as the foundation, and supported by computing power, data, and algorithms, unveiled the “X-SOUL AI Panorama.” The vision for a better future of human mobility is realized through four key scenarios—”Sky, People, Home, and Car”—actively shaping a new “AI+” full-scenario intelligent mobility ecosystem.

In flying cars, GAC has entered the “sky” space, creating a new framework for three-dimensional mobility. GAC has incubated the flying car brand GOVY, achieving the cross-industry integration of “automotive AI+ aviation safety.”

In robotics, GAC alleviates the pressure on “people,” making robots a companion in everyday life. With a dual-drive approach of “self-developed core hardware + building an industrial ecosystem,” GAC has already launched the third-generation embodied intelligent humanoid robot, GoMate.

In smart vehicle-home integration, GAC expands the “home” scenario, transforming the mobility experience into an extension of family life. GAC’s GoLife “Green Smart Vehicle-Home” integrated solution enables bidirectional connectivity between the vehicle and smart home systems.

In intelligent vehicles, GAC enriches the “car” concept, making the automobile a “smart mobile home.” In Q4, GAC aims to launch the country’s first L3-level conditional autonomous driving vehicle and the first factory-installed, mass-produced L4-level highly autonomous driving vehicle.

Currently, AI has become the core force driving transformation in the automotive industry. With AI empowerment, GAC introduces four flagship models, offering users smarter and safer mobility options.

In collaboration with Didi Autonomous Driving, GAC has launched the world’s first factory-installed, mass-produced L4-level highly autonomous driving vehicle with global adaptability.

Through deep collaborative innovation with Huawei Kunlun and CATL, GAC has developed the All-New S9, equipped with the latest Kunlun Intelligent Driving ADS 4 and HarmonyOS cockpit 5.

GAC also introduced its all-new shooting brake concept car-EARTH.

Moreover, GAC unveiled the GAC Pickup 01, a concept truck designed with technological aesthetics for global users.

2025 marks the third year of GAC’s “Panyu Action” taking effect. GAC will prioritize user needs, uphold the principles of safety first and intelligence at the core, and, guided by the “X- SOUL AI Panorama,” fully commit to building an “AI+” full-scenario intelligent mobility ecosystem, leading the new era of AI-driven transformation!

New metric empowers market participants to proactively monitor short squeeze risk by leveraging combined insights from market behavior, securities finance activity and social sentiment.

NEW YORK, April 23, 2025 /PRNewswire/ — EquiLend, the global leader in data and technology for the securities finance industry, has announced the launch of its Short Squeeze Score – a unique trading signal designed to provide an early warning of potential short squeezes. The signal enables traders, portfolio managers and risk teams to proactively mitigate risk in their portfolios by identifying the likelihood that a given security may be vulnerable to a short squeeze.

A short squeeze occurs when a heavily shorted security experiences a rapid price increase, forcing short sellers to cover positions and accelerating upward price pressure. The Short Squeeze Score is available across more than 50,000 unique equities in EquiLend’s suite of Data & Analytics Solutions, including DataLend, Orbisa and the Orbisa app on Bloomberg.

“With today’s market volatility and uncertainty, the ability to proactively identify the risk of a short squeeze is more valuable than ever,” said Nancy Allen, Head of Data & Analytics Solutions at EquiLend. “Built on our transaction-based securities finance data, our score brings greater transparency to the global short sale market—and we’re excited to share it.”

Three Powerful Data Pillars Behind the Score
The Short Squeeze Score provides a holistic risk signal derived from three critical dimensions:

• Market Dynamics
• Securities Finance Data
• Social Sentiment

By combining these data sets, the Short Squeeze Score not only reflects current conditions but anticipates potential emerging risks for market participants. In back-testing, the score has shown strong historical correlation with prior squeeze events, such as the January 2021 GameStop short squeeze.

“This launch underscores our dedication to providing DataLend and Orbisa customers with data-driven insights that enable them to anticipate market trends, manage risk and drive innovation in their decision process,” said Nick Delikaris, Chief Product Officer at EquiLend.

For more information about the EquiLend Short Squeeze Score or to request a demo, please visit EquiLend.com.

About EquiLend

EquiLend is a leading global financial technology firm providing Trading, Post-Trade, Data & Analytics, RegTech, and Platform Solutions to the securities finance industry. With a presence across North America, EMEA, and Asia-Pacific, EquiLend operates in multiple jurisdictions, upholding the highest regulatory standards.

Renowned for its commitment to innovation and operational excellence, EquiLend continues to drive efficiency and automation in the industry. The company is Great Place to Work Certified™ in the U.S., UK, Ireland, and India and has received industry recognition, including Americas and EMEA Data Provider of the Year and Regulatory Solution of the Year at the Securities Finance Times Industry Excellence Awards 2024.

For more information, visit www.equilend.com.

Media Contacts
Andrew.Fern@equilend.com

NEW YORK, April 23, 2025 /PRNewswire/ — Confidential computing is poised to become essential for data protection, bolstered by other privacy technologies and software. It’s driving significant growth opportunities for vendors in both the hardware and software sectors. ABI Research, a global technology intelligence firm, expects overall confidential computing revenue to reach US$160 billion by 2032, at a compound annual growth rate (CAGR) of 44%. This growth is driven by advances in confidential virtual machines (VMs), GPU-based compute, and the expansion of secure enclaves across systems. Along with ongoing efforts by the Confidential Computing Consortium, confidential computing remains a top priority for both vendors and data protection organizations.

“While confidential computing is still in its early stages, the market is approaching a turning point due to key advancements in both hardware and software,” explains Aisling Dawson, Industry Analyst at ABI Research. “GPU-based confidential computing has reignited demand, especially for AI and ML applications. The shift toward hardware-agnostic solutions that extend enclave protection across ecosystems will drive revenue opportunities for vendors beyond just processor providers. Meanwhile, specialized software and as-a-service offerings, particularly those focused on infrastructure and application agnosticism, are poised to capture a significant share of the market.”

The confidential computing market boasts strong players capable of prolonged and intense investment, backing a strong growth trajectory in this segment. This includes hardware giants like Intel and AMD, as well as breakout providers in the Trusted Execution Environment (TEE) subsegment, such as Arm. Additionally, pioneers in the GPU subsegment, such as NVIDIA, lead the way with regard to AI and ML applications. Primary contenders in the software space include Anjuna Seaglass, Fortanix, Decentriq, and Edgeless Systems. Mass migration to the cloud contributes to growing demand for innovative new cloud-security solutions from cloud service providers, drawing in hyperscalers like Google, Microsoft, and Amazon into the wider confidential computing ecosystem.    

With some remaining resistance, particularly regarding costs and migration complexities associated with transitioning to systems secured by confidential compute, adoption is not expected to be widespread before 2032. Dawson advises, “To succeed in this growing market, vendors must focus on solutions that address specific data protection needs, such as multi-party data collaboration and AI/ML security. Developing products on confidential computing hardware will help demonstrate its value and drive adoption. Additionally, exploring how confidential computing integrates with other privacy technologies, particularly in balancing input privacy with techniques like homomorphic encryption and multi-party computation for output privacy, will accelerate its mainstream adoption.”

These findings are from ABI Research’s Confidential Computing: Hardware report. This report is part of the company’s Quantum Safe Technologies and Trusted Device Solutions research services, which include research, data, and ABI Insights.

About ABI Research

ABI Research is a global technology intelligence firm uniquely positioned at the intersection of technology solution providers and end-market companies. We serve as the bridge that seamlessly connects these two segments by providing exclusive research and expert guidance to drive successful technology implementations and deliver strategies proven to attract and retain customers.

ABI Research是一家全球性的技术情报公司，拥有得天独厚的优势，充当终端市场公司和技术解决方案提供商之间的桥梁，通过提供独家研究和专业性指导，推动成功的技术实施和提供经证明可吸引和留住客户的战略，无缝连接这两大主体。

For more information about ABI Research’s services, contact us at +1.516.624.2500 in the Americas, +44.203.326.0140 in Europe, +65.6592.0290 in Asia-Pacific, or visit www.abiresearch.com.

Contact Info:

Global                                                             
Deborah Petrara                                                           
Tel: +1.516.624.2558                                                   
pr@abiresearch.com